Effects of metronidazole and tinidazole ointments on models for inflammatory dermatitis in mice

Archives of Dermatological Research

Volumn 294, Issue 12, 2003, Pages 544-551

  Nishimuta, K ^a   Ito, Y ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Dermatitis; Inflammatory; Metronidazole; Mouse; Ointment; Tinidazole

Indexed keywords

2,4 DINITROPHENOL; ANTIGEN; HAPTEN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; METRONIDAZOLE; MONOCLONAL ANTIBODY; OVALBUMIN; TACROLIMUS; TINIDAZOLE;

ACNE VULGARIS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATOPIC DERMATITIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; DERMATITIS; DOSE RESPONSE; DRUG EFFICACY; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY DISEASE; MALE; MOUSE; NONHUMAN; OINTMENT; PRIORITY JOURNAL; PRURITUS; ROSACEA; SCRATCHING; SENSITIZATION;

EID: 0037353331     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-002-0381-4     Document Type: Article

References (29)

1. Wilkin J (1999) Use of topical products for maintaining remission in rosacea. J Arch Dermatol 135:79-80
2. Parsad D, Pandhi R, Negl KS, Kuma B (2001) Topical metronidazole in seborrheic dermatitis. Dermatology 202:35-37
3. Nair MD, Nagarajan K (1983) Nitroimidazole as chemotherapeutic agents. Prog Drug Res 27:163-252
4. Bannatype RM (1999) Metronidazole, its bioactive metabolites and acne. Clin Med Res Opin 15:289-299
5. Rockwell S, Irvin CG, Hederlank MH (1983) Inhibition of delayed hypersensitivity by metronidazole and misonidazole. Int J Radiat Oncol Biol Phys 9:701-706
6. Kohli J, Bhattacharya SK, Gupta VS, Sen P (1987) Effect of metronidazole on immune mechanism in experimental animals. Indian J Exp Biol 25:177-180
7. Sen P, Chakaravarty AK, Kohli J (1991) Effects of some imidazoles on cellular immune responses. An experimental study. Indian J Exp Biol 29:867-869
8. Grewe M, Bruijnzeal-Koomen CAFM, Schöpf E, Thepen T, Langeveld-Wildschut AG, Ruzicka T, Krutmann J (1998) A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today 19:359-361
9. Carmine AA, Brogden RN, Heel RC, Speight TM, Avery GS (1982) Tinidazole in anaerobic infections. A review of its antibacterial activity, pharmacological properties and therapeutic efficacy. Drugs 24:85-117
10. Kitagaki H, Fujisawa S, Watanabe K, Hayakawa K, Shiohara T (1995) Immediate-type hypersensitivity response followed by a late reaction is induced by repeated epicutaneous application of contact sensitizing agents in mice. J Invest Dermatol 105:749-755
11. Leung DY, Hirsch RL, Schneider L, Moody C, Takaoka R, Li SH, Meyerson LA, Mariam SG, Goldstein G, Hanifin JM (1990) Thymopentin therapy reduces the clinical severity of atopic dermatitis. J Allergy Clin Immunol 85:927-933
12. Katayama I, Tanei R, Yokozeki H, Nishioka K, Doi Y (1990) Induction of eczematous skin reaction in experimentally induced hyperplastic skin of Balb/C mice by monoclonal anti-DNP IgE antibody: possible implications for skin lesion formation in atopic dermatitis. Int Arch Allergy Appl Immunol 93:148
13. Rogers DF, Boschetto P, Barnes PJ (1989) Plasma exudation: correlation between Evans blue dye and radiolabeled albumin in guinea-pig airways in vivo. J Pharmacol Methods 21:309-315
14. Akamatsu H, Oguchi M, Nishijima S, Asada Y, Takahashi M, Ushijima T, Niwa Y (1990) The inhibition of free radical generation by human neutrophils through the synergistic effects of metronidazole with palmitoleic acid: a possible mechanism of action of metronidazole in rosacea and acne. Arch Dermatol Res 282:449-454
15. Saihan EM, Burton JL (1980) A double-blind trial of metronidazole versus oxytetracycline therapy for rosacea. Br J Dermatol 102:443-444
16. von Prinz L (1960) Die Behandlung der Rosacea papulopustulosa mit metronidazole (Vagimid). Dsch Gesundheits-Wesen 35:1804-1805
17. Nielsen PG (1983) Treatment of rosacea with 1% metronidazole cream. A double-blind study. Br J Dermatol 108:327-332
18. Breneman D, Stewart D, Hevia O, Hino PD, Drake LA (1998) A double-blind, multicenter clinical trial comparing efficacy of one-daily metronidazole 1 percent cream to vehicle in patients with rosacea. Cutis 61:44-47
19. Jorizzo JL, Lebwohl M, Tobey RE (1998) The efficacy of metronidazole 1% cream once daily compared with metronidazole 1% cream twice daily and their vehicles in rosacea; a double-blind clinical trial. J Am Acad Dermatol 39:502-504
20. Miyachi Y, Simamura S, Niwa Y (1986) Anti-oxidant action of metronidazole: a possible mechanism of action in rosacea. Br J Dermatol 114:231-234
21. Hamid Q, Boguniewicz MZ, Leung DY (1994) Differential in situ cytokine gene expression in acute versus chronic atopic dermatitis. J Clin Invest 94:870-876
22. Grewe M, Gyufko K, Schopf E, Krutmann J (1994) Lesional expression of interferon-γ in atopic eczema. Lancet 343:25-26
23. Ohmen JD, Hanifin JM, Nickoloff BJ, Rea TH, Wyzykowski R, Kim J, Jullien D, McHugh T, Nassif AS, Chan SC, et al (1995) Overexpression of IL-10 in atopic dermatitis. Contrasting cytokine patterns with delayed type hypersensitivity reactions. J Immunol 154:1956-1963
24. Tanaka Y, Anan S, Yoshida H (1990) Immunohistochemical studies in mite antigen-induced patch test sites in atopic dermatitis. J Dermatol Sci 1:361-368
25. Kitagaki H, Ono N, Hayakawa K, Kitazawa T, Watanabe K, Shiohara T (1997) Repeated elicitation of contact hypersensitivity induces a shift in cutaneous cytokine milieu from a T helper cell type1 to a T helper cell type2 profile. J Immunol 159:2484-2491
26. Nagai H, Sakura T, Inagaki N, Mori H (1995) An immunopharmacological study of the biphasic allergic reaction in mice. Biol Pharm Bull 18:229-245
27. Miller JJ (1980) The imidazoles as immunosuppressive agents. Transplant Proc 12:300-303
28. Rockwell S, Kapp DS (1982) Immunosuppression by hypoxic cell radiosensitizers. A phenomenon of potential clinical importance. Int J Radiat Oncol Biol Phys 8:1071-1074
29. Roe FJ (1985) Safety of nitroimidazoles. Scand J Infect Dis Suppl 46:72-81